Overview

Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia

Status:
Completed

Trial end date:
2007-08-01

Target enrollment:

Participant gender:

Summary

OBJECTIVES: I. Compare outcome, including graft failure, graft versus host disease, and survival of HLA-identical sibling bone marrow transplants for aplastic anemia using cyclophosphamide with or without antithymocyte globulin as a conditioning regimen.

Phase:

Phase 3

Details

Lead Sponsor:

Roswell Park Cancer Institute

Treatments:

Antilymphocyte Serum
Cyclophosphamide